Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Levothyroxine 150 mcg (Tecnoquimicas vs Merck)
NCT03634371Phase 4Unknown
- Sponsor
- Tecnoquímicas S.A.
- Start
- Aug 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Tecnoquímicas S.A. Primary endpoints: Area Under the Curve 0-48 hours for T4 and Maximum Serum Concentration for T4. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT03634371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634371.